Orchid Pharma Elevates Arjun Dhanuka to Whole-Time Director and Appoints Cost Auditor
Orchid Pharma Ltd 路 Change in Management 路 04 Sept 2026, 1:59 am
Orchid Pharma Elevates Arjun Dhanuka to Whole-Time Director and Appoints Cost Auditor On 3rd Sep'26, Orchid Pharma's board approved elevating Mr. Arjun Dhanuka from Non-Executive to Whole-Time Director for a five-year term ending 2nd Sep'31. The board also appointed M/s. J Karthikeyan & Associates as Cost Auditors for FY 2026-27. Furthermore, the company scheduled its 33rd AGM for 29th Sep'26, establishing 22nd Sep'26 as the cut-off date for e-voting eligibility. The remote e-voting window will operate from 26th Sep'26 to 28th Sep'26.
Original exchange filing (PDF)
More announcements from Orchid Pharma Ltd
- Audio Recording of the Analysts/Investors Earnings Call - Orchid Pharma Limited ('the Company') 路 18 Nov 2026
- Board Comments on fine levied by Stock Exchanges 路 17 Nov 2026
- Investor Presentation-Quarter II of FY 2026-27, ended on September 30, 2026 路 17 Nov 2026
- Statement of deviation or variation for the quarter ended on September 30, 2026 on the use of proceeds of funds raised through Qualified institutional placement (QIP) 路 14 Nov 2026
- Declaration of Financial results for quarter and half year ended on September 30, 2026 路 14 Nov 2026
- Outcome of Board Meeting 路 14 Nov 2026
- Orchid Pharma Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 14 Nov 2026
- Monitoring Agency Report for the Quarter-II ended on September 30, 2026 路 14 Nov 2026
